Developments Percheron secures pINN from WHO for investigational cancer therapy Percheron Therapeutics (ASX: PER; OTC: PERCF) has secured a potential international nonproprietary name (pINN) from the World Health Organization (WHO) for its investigational cancer therapy HMBD-002. According to... May 26, 2026